Flucelvax (Optaflu) for seasonal influenza

Area of Science:

• Vaccinology
• Virology
• Public Health

Background:

• Conventional egg-based influenza vaccine manufacturing faces challenges including inflexibility, supply chain reliance, contamination risks, and potential for egg-adaptive viral mutations.
• Cell culture-derived vaccines present an alternative manufacturing platform to overcome these limitations.
• Flucelvax®/Optaflu® (trivalent inactivated influenza vaccine) is a cell culture-derived vaccine with increasing regulatory approval and global implementation.

Purpose of the Study:

• To provide an updated review of the clinical development and performance of Flucelvax®/Optaflu®.
• To summarize seasonal trial data and post-marketing surveillance findings for this cell culture-derived influenza vaccine.
• To address non-clinical findings regarding safety and immunogenicity in various populations.

Main Methods:

• Review of non-clinical studies assessing oncogenicity and safety in individuals with dog allergies.
• Analysis of clinical trial data comparing Flucelvax®/Optaflu® to egg-based vaccines regarding immunogenicity, safety, and tolerability.
• Examination of post-marketing surveillance data and pediatric study outcomes.

Main Results:

• Non-clinical studies have not indicated concerns regarding oncogenicity or contraindications for individuals with dog allergies.
• Clinical data demonstrate the non-inferiority of Flucelvax®/Optaflu® compared to egg-based vaccines in terms of immunogenicity, safety, and tolerability, meeting regulatory standards.
• Pediatric data suggest good immunogenicity and safety, although current indications are for adults and the elderly.

Conclusions:

• Flucelvax®/Optaflu® represents a viable and effective alternative to egg-based influenza vaccines.
• The vaccine has demonstrated a favorable safety and immunogenicity profile across different age groups.
• Continued post-marketing surveillance and clinical evaluation will further support the role of cell culture-derived vaccines in seasonal influenza prevention.